Is ELISA Obsolete? Why It Remains Irreplaceable in the Era of Multiplex Immunoassays
In the fast-developing field of biomedical research, why does a technology with over 50 years of history like ELISA still hold a dominant position in immunoassays? Even with the continuous advancement of immunoassay technologies, ELISA remains the top choice for the reliable and accurate detection of proteins, antibodies, and hormones. But what makes ELISA the preferred method, even when newer technologies such as multiplex immunoassays offer the prospect of obtaining more data in a shorter time?
1
What is ELISA?
ELISA is a widely used singleplex immunoassay technique for the qualitative and quantitative analysis of antigens or antibodies in various samples. The core principle of ELISA is based on the specific binding between an antigen and an antibody; this binding is then detected through an enzyme-labeled secondary antibody, which generates a measurable signal (usually a color change) when a substrate is added.
There are four main types of ELISA:
Direct ELISA
Involves the direct binding of an enzyme-labeled antibody (or antigen) to the antigen (or antibody) immobilized on the surface of a microtiter plate. Subsequently, the enzyme attached to the antibody (or antigen) reacts with its substrate to produce a visible signal, which can be measured using a spectrophotometer. Direct ELISA is simple to operate but may have lower sensitivity compared to other types.
Indirect ELISA
Adopts a two-step binding process involving a primary antibody and an enzyme-labeled secondary antibody. First, the primary antibody binds to the immobilized antigen, and then it interacts with the enzyme-labeled secondary antibody, leading to color development. This method improves sensitivity but is more complex and costly due to the need for an additional antibody.
Sandwich ELISA
Requires two antibodies that are specific to different epitopes of the same antigen. This format starts with the immobilization of a capture antibody on the microtiter plate. The antigen in the sample binds to the immobilized capture antibody and is then "sandwiched" with an enzyme-labeled detection antibody to trigger color development. This method boasts high sensitivity and is commonly used for detecting proteins in complex samples.
Competitive ELISA
Refers to a process where sample antigens compete with enzyme-labeled antigens for binding to a limited number of antibody sites. The intensity of the signal produced is inversely proportional to the concentration of the target antigen in the sample. This method is particularly suitable for small antigens or when the target is present in low concentrations.
2
What are Multiplex Immunoassays?
Multiplex immunoassays are advanced analytical techniques capable of detecting multiple analytes simultaneously from a single sample in one run. The multiplexing approach greatly reduces the required sample volume and analysis time, thereby facilitating high-throughput screening and personalized medicine. These assays have become increasingly popular in fields that require comprehensive profiling of biological systems, such as multiplex cytokine assays in immune response studies or cancer biomarker analysis.
Multiplex immunoassays follow the basic principles of traditional immunoassays. However, instead of using only one primary antibody, they employ multiple primary antibodies, each targeting a different analyte.
Nearly all traditional immunoassays can be adapted into a multiplexed format. Multiplex immunoassays are divided into two categories based on the type of surface on which antibodies or antigens are immobilized: planar assays and suspension microsphere assays.
Planar assays
Multiple capture antibodies are immobilized on two-dimensional supports (such as slides or microplates) and probed with a sample, followed by the addition of chemiluminescent/fluorescent reporter-labeled detection antibodies. The chemiluminescent or fluorescent signals are detected using a high-resolution scanner and identified by their xy coordinates. The planar format is advantageous for high-density applications, allowing thousands of individual tests to be performed in parallel, thus enabling high-throughput screening.
Suspension immunoassays
Capture antibodies are immobilized on fluorophore-coded microspheres, which are then treated with the sample, followed by the addition of fluorescently-tagged detection antibodies. Each microsphere forms a "sandwich" structure containing the captured target analyte and the corresponding reporter-conjugated detection antibody. Flow cytometry is used to detect the assay-specific fluorescent signals in the beads. Bead-based immunoassays overcome mass transport limitations through active mixing in the liquid sample.
3
ELISA vs. Multiplex Immunoassays: Key Differences
Both ELISA and multiplex immunoassays are crucial techniques in the field of immunoassays, yet they have distinct characteristics that affect their application in clinical and research settings.
| Feature | ELISA | Multiplex Immunoassays |
|---|---|---|
| Detection Capacity | Single analyte detection per assay | Simultaneous detection of multiple analytes per assay |
| Sample Volume | Requires larger sample volume for multiple analytes | A single sample measures multiple analytes |
| Sensitivity | High sensitivity for individual analytes | Lower sensitivity due to multi-analyte detection |
| Specificity | Very high specificity | Moderate specificity with cross-reactivity risk |
| Time Efficiency | Time-consuming for multiple analytes | High efficiency in single run |
| Cost & Equipment | Affordable standard equipment | Higher initial specialized equipment cost |
| Data Analysis | Simple and straightforward | Complex with professional software required |
| Ease of Use | Easy to perform | Complex with technical expertise needed |
| Accuracy | Very accurate and reliable | Less reliable for low-abundance analytes |
| Reproducibility | Highly reproducible | Variable reproducibility |
4
Why ELISA Remains the First Choice
Despite the emergence of multiplex assays, ELISA continues to be the preferred method for many immunoassays, especially in clinical diagnostics and focused research applications.
4.1 High Sensitivity and Specificity
ELISA can accurately detect and quantify individual analytes with high sensitivity and specificity. The use of highly selective antibodies ensures precise results with minimal cross-reactivity, delivering reliable data for diagnostics and research.
4.2 Simplicity and Accessibility
ELISA procedures are straightforward and easy to standardize across laboratories. Required equipment is standard in most labs, and results can be interpreted without advanced bioinformatics support.
4.3 Well-Established Protocols
ELISA has decades of validated use across countless applications. It is trusted for reliability and accuracy, with highly reproducible results between experiments.
4.4 Cost-Effectiveness
For single or dual analyte measurement, ELISA is far more economical. Reagents and equipment are widely available and affordable for most laboratory budgets.
4.5 Versatility
ELISA adapts to multiple formats (direct, indirect, sandwich, competitive) for diverse applications in immunology, infectious diseases, oncology, and pharmacology.
Conclusion
While multiplex assays offer powerful multi-analyte detection, ELISA remains the gold standard for precision, simplicity, and cost-effectiveness. Its unmatched sensitivity, specificity, and ease of use make it indispensable for targeted research and clinical diagnostics.
Multiplex assays excel in high-throughput profiling, but ELISA is irreplaceable for accurate, reliable quantification of individual analytes.
References
- K. Okada and K. Matsuo, Development of new antibodies and ELISA system to detect potato alkaloids [J]. Foods, 2023.
- Davies C. Principles of competitive and immunometric assays (including ELISA) [J]. Immunoass Handbook, 2013.
- Rasmussen M, et al. Evaluation of a competitive ELISA for soluble HLA-G protein [J]. Tissue Antigens, 2014.
- Li D, et al. Integrated protein and glycan analysis in multiplex magnetic bead assays [J]. Clinical Chemistry, 2013.
- Guo W, et al. Multiplex electrochemiluminescence immunoassay [J]. JACS, 2018.
- Tighe PJ, et al. ELISA in the multiplex era: potentials and pitfalls [J]. Proteomics, 2015.